FDA to review Moderna's mRNA flu vaccine
Digest more
Two hurdles mRNA drugs face are a short half-life and impurities that trigger immune responses. BlackJack3D/iStock via Getty Images Plus Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Moderna and the BioNTech-Pfizer duo became heroes of the COVID-19 pandemic with vaccines that saved millions of ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. The U.S. federal government has moved to cut millions of dollars in funding for mRNA vaccine development. | Credit: SOPA Images via Getty Images But now ...